TwinStrand Biosciences raises $1.2M toward $4M round to commercialize Duplex Sequencing that detects tiny DNA mutations

TwinStrand Biosciences, a University of Washington spin-out, is raising up to $4 million (having secured $1.2 million so far) to commercialize Duplex Sequencing, a method that sequences and compares both DNA strands to remove noise and detect tiny mutations invisible to standard sequencers.

No comments yet.